Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|April 24, 2023
Study of Protein Conformational Dynamics Using Hydrogen/Deuterium Exchange Mass SpectrometryLukas Uhrik, Tomas Henek, Joan Planas-Iglesias, et al.
Plos One|November 4, 2024
Direct activation of HSF1 by macromolecular crowding and misfolded proteinsOliver Simoncik, Vlastimil Tichy, Michal Durech, et al.
Frontiers in Genetics|November 20, 2024
Misincorporations of amino acids in p53 in human cells at artificially constructed termination codons in the presence of the aminoglycoside GentamicinKamila Pawlicka, Tomas Henek, Lukas Uhrik, et al.
The Biochemical Journal|October 26, 2019
Allosteric changes in HDM2 by the ATM phosphomimetic S395D mutation: implications on HDM2 functionLukas Uhrik, Lixiao Wang, Lucia Haronikova, et al.
International Journal of Biological Macromolecules|January 22, 2022
Serum albumin as a primary non-covalent binding protein for nitro-oleic acidLenka Hernychova, Eleni Alexandri, Andreas G Tzakos, et al.
Bioscience Reports|June 8, 2022
Cryptic in vitro ubiquitin ligase activity of HDMX towards p53 is probably regulated by an induced fit mechanismKarla Gisel Calderon-González, Ixaura Medina-Medina, Lucia Haronikova, et al.
Scientific Reports|January 3, 2024
N-glycan profiling of tissue samples to aid breast cancer subtypingIva Benesova, Rudolf Nenutil, Adam Urminsky, et al.
Journal of Proteomics|September 8, 2020
N-Glycome changes reflecting resistance to platinum-based chemotherapy in ovarian cancerMartina Zahradnikova, Ivana Ihnatova, Erika Lattova, et al.
Molecular & Cellular Proteomics : MCP|April 11, 2024
Multi-Omic Analysis of Esophageal Adenocarcinoma Uncovers Candidate Therapeutic Targets and Cancer-Selective Posttranscriptional RegulationJ Robert O'Neill, Marcos Yébenes Mayordomo, Goran Mitulović, et al.
The Biochemical Journal|December 7, 2020
Hydrogen deuterium exchange mass spectrometry identifies the dominant paratope in CD20 antigen binding to the NCD1.2 monoclonal antibodyLukas Uhrik, Lenka Hernychova, Petr Muller, et al.
Pageof 2